HEMOGENYX PHARMPLC (Germany) Today
| 5HU Stock | EUR 4.14 0.62 13.03% |
Performance9 of 100
| Odds Of DistressLess than 24
|
HEMOGENYX PHARMPLC is trading at 4.14 as of the 18th of December 2024. This is a 13.03% down since the beginning of the trading day. The stock's lowest day price was 4.0. HEMOGENYX PHARMPLC has about a 24 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. HEMOGENYX PHARMPLC has reported 400 for 1 split on 13th of December 2024. The performance scores are derived for the period starting the 29th of December 2022 and ending today, the 18th of December 2024. Click here to learn more.
Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases. The company was incorporated in 2013 and is headquartered in London, the United Kingdom. The company has 979.75 M outstanding shares. More on HEMOGENYX PHARMPLC LS 01
Moving against HEMOGENYX Stock
HEMOGENYX Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. HEMOGENYX PHARMPLC's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding HEMOGENYX PHARMPLC or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
HEMOGENYX PHARMPLC LS 01 (5HU) is traded on Frankfurt Exchange in Germany and employs 10 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 24.89 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate HEMOGENYX PHARMPLC's market, we take the total number of its shares issued and multiply it by HEMOGENYX PHARMPLC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. HEMOGENYX PHARMPLC classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 979.75 M outstanding shares.
HEMOGENYX PHARMPLC LS 01 has accumulated about 1.81 M in cash with (1.8 M) of positive cash flow from operations.
Check HEMOGENYX PHARMPLC Probability Of Bankruptcy
Ownership AllocationHEMOGENYX PHARMPLC LS 01 has a total of 979.75 Million outstanding shares. HEMOGENYX PHARMPLC retains 15.17 (percent) of its outstanding shares held by insiders and 0.0 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check HEMOGENYX Ownership Details
HEMOGENYX PHARMPLC Risk Profiles
Although HEMOGENYX PHARMPLC's alpha and beta are two of the key measurements used to evaluate HEMOGENYX PHARMPLC's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 69.56 | |||
| Semi Deviation | 17.26 | |||
| Standard Deviation | 271.92 | |||
| Variance | 73938.35 |
HEMOGENYX Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in HEMOGENYX PHARMPLC without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Theme Ratings Now
Theme RatingsDetermine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Other Information on Investing in HEMOGENYX Stock
HEMOGENYX PHARMPLC financial ratios help investors to determine whether HEMOGENYX Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HEMOGENYX with respect to the benefits of owning HEMOGENYX PHARMPLC security.